Expectations concerning cancer treatment: perspectives of medical oncologists and patients on advanced, unresectable lung carcinoma
- PMID: 39444838
- PMCID: PMC11496176
- DOI: 10.3389/fpsyg.2024.1392567
Expectations concerning cancer treatment: perspectives of medical oncologists and patients on advanced, unresectable lung carcinoma
Abstract
Introduction: This study seeks to compare expectations regarding systemic cancer treatment for advanced lung cancer from the perspectives of both patient and medical oncologist.
Methods: A cross-sectional study involving 17 medical oncologists from 13 Spanish hospitals between 2021 and 2022. Patients with advanced, unresectable lung cancer were recruited prior to initiating systemic cancer treatment. Both patients and oncologists completed the NEOetic-EIT and the STAR.
Results: Seventeen medical oncologists specializing in lung cancer participated, with a mean age of 36.2 years (range 28-56); 65% were female. The study included 298 patients with advanced, unresectable lung cancer, predominantly non-small cell type (72%), and most at stage IV (77%). Most patients were retired or unemployed (71%), and married or partnered (77%). Treatment approaches varied, with 44% based on biomarkers. Oncologists had greater expectations of positive outcomes for participants with better baseline prognosis, such as ECOG 0, newly diagnosed, locally advanced, unresectable non-small cell lung cancer, and those receiving biomarker-based treatments. In contrast, patients' treatment expectations did not vary based on sociodemographic or clinical factors. Generally, patients had high expectations of cure, in contrast to oncologists' lower expectations, though both anticipated similar quality-of-life improvements. Patients anticipated more side effects than oncologists. Among oncologists, expectations varied by gender and decreased with age and experience, with no differences detected among patients based on gender, age, or doctor-patient relationship.
Conclusion: This study reveals the complex expectations of patients and oncologists in advanced lung cancer treatment. It underscores the need for effective communication in oncology to align patient expectations with clinical realities.
Keywords: cancer treatment; expectation; lung cancer; oncologist; prognosis; toxicity.
Copyright © 2024 Cruz-Castellanos, Jiménez-Fonseca, Galán-Moral, Piera-Molons, Gustems and Calderon.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Determinants of Patient-Oncologist Prognostic Discordance in Advanced Cancer.JAMA Oncol. 2016 Nov 1;2(11):1421-1426. doi: 10.1001/jamaoncol.2016.1861. JAMA Oncol. 2016. PMID: 27415765 Free PMC article.
-
Prognostic communication about lung cancer in the precision oncology era: A multiple-perspective qualitative study.Cancer. 2022 Aug 15;128(16):3120-3128. doi: 10.1002/cncr.34369. Epub 2022 Jun 22. Cancer. 2022. PMID: 35731234
-
Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.Med Care. 2000 Nov;38(11):1103-18. doi: 10.1097/00005650-200011000-00005. Med Care. 2000. PMID: 11078051
-
Patients' and Oncologists' Knowledge and Expectations Regarding Tumor Multigene Next-Generation Sequencing: A Narrative Review.Oncologist. 2021 Aug;26(8):e1359-e1371. doi: 10.1002/onco.13783. Epub 2021 Apr 21. Oncologist. 2021. PMID: 33823080 Free PMC article. Review.
-
Homologous Recombination Deficiency Testing to Inform Patient Decisions About Niraparib Maintenance Therapy for High-Grade Serous or Endometrioid Epithelial Ovarian Cancer: A Health Technology Assessment.Ont Health Technol Assess Ser. 2023 Aug 10;23(5):1-188. eCollection 2023. Ont Health Technol Assess Ser. 2023. PMID: 37637244 Free PMC article.
References
-
- Associatin of American Medical Colleges . The state of women in academic medicine 2018–2019. (2020). Available at:https://www.aamc.org/data-reports/data/2018-2019-state-women-academic-me...
-
- Basch E., Iasonos A., McDonough T., Barz A., Culkin A., Kris M. G., et al. . (2006). Patient versus clinician symptom reporting using the National Cancer Institute common terminology criteria for adverse events: results of a questionnaire-based study. Lancet Oncol. 7, 903–909. doi: 10.1016/S1470-2045(06)70910-X - DOI - PubMed
LinkOut - more resources
Full Text Sources